Two Zika vaccine candidates shown to completely protect mice from the virus
by Loren Grush
CNBC Healthcare, June 29th, 2016
The vaccines still need to go through human clinical trials.
Entries by Academic Web Pages
New Studies Show Just How Tricky the Zika Virus Is
NBC News by MAGGIE FOX A batch of new studies show the Zika virus is trickier than it appeared at first glance, lurking for months in pregnant females and interfering […]
How An Electric Shock Could One Day Protect You From Zika
Heard on All Things Considered MICHAELEEN DOUCLEFF This summer, it’s not just athletes who are looking to set world records. Scientists are also trying to break a record — for […]
Zika Vaccine Under Development by Boston Researchers
WCVB5 ABC Virus delared global health emergency A vaccine to protect against the Zika virus is in the works under a research team led by scientists at the Beth Israel […]
2 Types of Vaccines Protect Against Zika Virus in Mice: Interview
WBUR By Jonathan Cain “We hope that this news will electrify and galvanize the vaccine effort against Zika virus,” says Dr. Dan Barouch of Beth Israel Deaconess Medical Center and […]
Breakthrough Zika Vaccine Under Development by Boston Researchers
The Boston Herald Lindsay Kalter A group of researchers at Beth Israel Deaconess Medical Center are testing a vaccine for the Zika virus they say has exceeded expectations in animal […]
Two New Vaccines Protect Mice From Zika Virus Infection
STAT News
- By: Andrew Joseph @DrewQJoseph
Two new experimental vaccines protect mice against the Zika virus, a study out Tuesday shows.
Researchers from governments, academic labs, and biopharma companies have been rushing to develop Zika vaccines since global health experts started warningabout the previously unknown dangers wrought by the mosquito-borne virus, including serious birth defects. Just last week, the Food and Drug Administration approved the first human testing of a Zika vaccine candidate from the company Inovio Pharmaceuticals.
Inside the U.S. Army Lab Racing to Create a Zika Vaccine
Wired Magazine Eric Niller Rafael de la Barrera reaches into a freezer and pulls out a plastic jug of rusty-red liquid. He wipes frost off the label: “Zika Virus – […]
Top HIV Scientists Awarded $42 Million in National Institutes of Health Funding to Improve Efficacy of HIV Vaccine Platforms
BIDMC, OHSU to Lead Consortium Exploring Vaccine Candidate and Cure Strategies
- BIDMC Contact: Jennifer Kritz
- Phone: 617-667-7301
- Email: jkritz@bidmc.harvard.edu
- Boston Magazine
BOSTON – With $42 million in funding from the National Institutes of Health, scientists from Beth Israel Deaconess Medical Center (BIDMC) and Oregon Health & Science University (OHSU) will lead a five-year research initiative to advance efforts to cure and prevent HIV/AIDS. Dan Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research at BIDMC, and Louis Picker, MD, Assistant Director of the OHSU Vaccine and Gene Therapy Institute, will lead a consortium of researchers from across the country exploring the mechanisms behind promising new HIV vaccine candidates and potential cure strategies.
Researchers Uncover Earliest Events Following HIV Infection, Before Virus Is Detectable
Findings Could Lead to New HIV Prevention Strategies
- BIDMC Contact: Jennifer Kritz
- Phone: 617-667-7301
- Email: jkritz@bidmc.harvard.edu
BOSTON – New research in monkeys exposed to SIV, the animal equivalent of HIV, reveals what happens in the very earliest stages of infection, before virus is even detectable in the blood, which is a critical but difficult period to study in humans. The findings, published online today in the journal Cell, have important implications for vaccine development and other strategies to prevent infection.
